Document Actions
Clinical Pathology
Up one levelFaculty Listing for Clinical Pathology
Ed Ashwood, M.D.
Dr. Ashwood is senior vice president and director of laboratories for University of Utah owned ARUP Laboratories. In addition to his laboratory director duties, he teaches, conducts clinical research, co-edits 3 textbooks, and co-directs the clinical chemistry postdoctoral fellowship program.
David Bahler, M.D., Ph.D.
Dr. Bahler's research interests include clinical applications of flow cytometry to diagnostic hematopathology, the role of chronic antigen stimulation and autoimmune disease in the development of lymphoid neoplasms, and the development and use of molecular hematopathology tests.
Pinar Bayrak-Toydemir, M.D., Ph.D.
Dr. Bayrak-Toydemir is the assistant medical director of Molecular Genetics ARUP. She also has an adjunct appointment as an assistant professor of pathology at the University of Utah School of Medicine.
Phillip Bernard, M.D.
Dr. Bernard is the medical director of the Solid Tumor Molecular Diagnostics Laboratory at ARUP. He is an assistant professor of pathology at the University of Utah School of Medicine.
Arthur Brothman, Ph.D.
Dr. Brothman has been Director of Cytogenetics at the University of Utah since 1991 and maintained a research laboratory looking at molecular and cytogenetic aspects of prostate cancer since 1986. His research work has primarily focused on genomic changes in cancers (prostate) and the application of new technologies to genetic diagnoses of acquired and constitutional abnormalities.
Judy Daly, Ph.D.
Dr. Daly focuses her research efforts on research in diagnostic techniques in clinical microbiology
Julio Delgado, M.D., M.S.
The focus of our research is to understand the functional role of the HLA system in the setting of transplantation and susceptibility to disease.
David Eckels, Ph.D.
Dr Eckels is interested in the HLA system because it controls the human immune response whether to transplanted tissue or viruses. His research interests have therefore focused on transplantation, immunoregulation, and viral immunology, specifically in regard to influenza and Hepatitis C viruses.
Mark Fisher, Ph.D.
Dr. Fisher’s research is aimed at understanding the molecular basis of infectious disease. Current projects involve investigations into the gene regulation and vector-borne transmission of Yersinia pestis.
Elizabeth Frank, Ph.D.
As an academic clinical chemist, Dr. Frank combines service, teaching, and research. She is Laboratory Director of the University Health Care Center Community Clinics Central Laboratory, Co-Director of the School of Medicine's Postdoctoral Training Program in Clinical Chemistry, and develops analytical methods for small molecules at ARUP Laboratories.
David G. Grenache, Ph.D.
Dr. Grenache is an Assistant Professor of Pathology at the University of Utah School of Medicine and is the Medical Director of the Special Chemistry Laboratory at ARUP Laboratories. He is board certified in clinical chemistry by the American Board of Clinical Chemistry. His main research interests include general clinical chemistry, reproductive endocrinology and biochemistry, and cancer biomarkers.
Patrice Held, Ph.D.
Dr. Held's research interests include the diagnosis and monitoring of patients with inherited metabolic disorders.
Harry Hill, M.D.
Dr. Hill’s research over the past 34 years, including over 30 years of NIH-funded work, is directed toward understanding the mechanism of host resistance to both group B and A streptococcal infections. This involved the study of opsonic antibodies, complement, and polymorphonuclear leukocytes, as well as, cytokines, and more recently, toll-like receptors in providing protection against these two major bacterial pathogens. He has also had a major interest in polymorphonuclear leukocyte diseases, specifically, Job syndrome of hyper IgE and recurrent infections and chronic granulomatous disease including more recently their molecular diagnosis.
Brian Jackson, M.D.
Dr. Jackson’s research focuses on measuring the appropriateness of laboratory testing in health care. This includes ecological studies of utilization patterns as well as cost effectiveness analysis to assess the economic impact of testing strategies.
Chris Lehman, M.D.
Dr. Lehman has focused his research efforts on clinical outcomes of laboratory testing.
Christine Litwin, M.D.
Dr. Litwin is a tenured full professor of pathology at the University of Utah and medical director of microbial immunology at ARUP Laboratories, University of Utah. Her basic research focus is in the bacterial pathogenesis of Bartonella henselae infections, (the causative agent of Cat Scratch Disease) and the identification of immunogenic proteins of this organism. Her clinical research interest is in the development and evaluation of new infectious disease serology tests particularly emerging infectious diseases, tuberculosis and zoonotic diseases, especially from pets. Dr. Litwin is the author of over 60 original articles.
Nicola Longo, M.D., Ph.D.
Dr. Longo's laboratory is investigating the molecular bases of carnitine deficiency. Current studies are identifying proteins interacting with the OCTN2 carnitine transporter that might contribute to cause disease is humans. New therapies are being evaluated for different metabolic disorders to include lysosomal storage disorders, organic acidemias, and disorders of amino acid metabolism.
Amy Lowichik, M.D., Ph.D.
Dr. Lowichik is a Board Certified Pediatric Pathologist in the Division of Pediatric Pathology, University of Utah SOM and based at Primary Children's Medical Center, whose work emphasizes anatomic surgical and autopsy pathology, with special interest in gastrointestinal pathology.
Elaine Lyon, Ph.D.
As a clinical scientist, Dr. Lyon directs molecular genetics at ARUP. She focuses on translational and clinical studies to identify genetic variants and diagnose inherited diseases. She co-directs the pharmacogenetics section, implementing testing to predict an individual’s response to medications.
Rong Mao, M.D.
Dr. Rong Mao is assistant professor of pathology at the University of Utah School of Medicine. Dr. Mao is the co-medical director in the molecular genetics section at ARUP and co-director for clinical molecular genetics fellowship training program
Gwendolyn A. McMillin, Ph.D.
Dr. McMillin is certified by the American Board of Clinical Chemistry in clinical chemistry and toxicological chemistry. Her research focuses on tools that support and improve drug therapy, including pharmacogenetic testing and methods for quantification of drugs and drug metabolites.
A. Wayne Meikle, M.D.
Dr. Meikle has focused on male reproductive endocrinology, prostatic and thyroid neoplasia and laboratory methodology for understanding molecular and pathophysiologic processes that regulate these disorders.
Marzia Pasquali, Ph.D.
Dr. Pasquali has focused her work in the study of inherited disorders of metabolism, with special emphasis on diagnostic methods and pre-symptomatic detection through newborn screening.
Theodore J. Pysher, M.D.
Pediatric Anatomic and Clinical Pathology, Nephropathology, Electron Microscopy
William Roberts, M.D., Ph.D.
Dr. Roberts has studied the performance characteristics of numerous clinical chemistry assays. Pediatric and adult reference intervals have been determined for many of them.
Karl Voelkerding, M.D.
Dr. Voelkerding's research efforts focus on the development and application of molecular biological methods for clinical diagnostic purposes.
Ron Weiss, M.D., M.B.A.
Dr. Weiss practices hematopathology, including hematologic flow cytometry; teaches medical students, pathology residents and fellows in both hematopathology and laboratory management; and is the President and Chief Operating Officer for ARUP Laboratories
Carl Wittwer, M.D., Ph.D.
Carl Wittwer is a Professor of Pathology at the University of Utah. He received his PhD from Utah State University and his MD from the University of Michigan. Dr. Wittwer’s research focuses on technique and instrument development in molecular diagnostics.
Lily Wu, Ph.D.
The major research efforts of Dr. Wu have been focused on studies concerning the risks of hypercholesterolemia, abnormal lipid profile, and the impact of genetic predisposition in the development of coronary heart diseases.